Mecuris GmbH: Financing EUR 3.6m

Wednesday, 16 January 2019 – Mecuris, a commercial stage company, teams up with certified prosthetists and orthotists (CPOs) to move orthopaedic care into the digital age.

Vesalius Biocapital III Partners joins Forendo Pharma Investor Syndicate

Wednesday, 5 September 2018 – Forendo Pharma today announces that it has raised an additional €4 million of funding from Vesalius Biocapital III Partners.

SWORD Health secures $4.6 million in seed funding

Monday, 16 April 2018 – SWORD Health, the creator of the AI-powered digital physiotherapist SWORD Phoenix, announces the close of its $4.6 million seed funding round.

Vesalius Biocapital Launches New Fund in Collaboration with Portuguese National Promotional Bank (IFD)

Tuesday, 19 September 2017 – First international investment by IFD. New fund will focus on investing in Portuguese life science companies

Fund 3 Announces First Close

Thursday, 18 May 2017 – New fund Vesalius Biocapital III to invest in later-stage European life sciences companies